世界の髄膜炎菌ワクチン市場は2023年に約34億8,000万米ドルと評価され、2024年から2032年の予測期間にわたって6.0%を超える健全な成長率で成長すると予想されています。
髄膜炎菌によって引き起こされる侵襲性髄膜炎菌感染症（IMD）は、髄膜炎や菌血症などの重篤な感染症を伴い、治療しない場合は致死率が50%にも達することがあります。この疾患は主に脳と脊髄の内層に影響を及ぼし、大規模な流行を引き起こす可能性があります。感染は、感染者または無症状の保菌者の呼吸器または喉の分泌物との直接接触によって起こります。髄膜炎菌の12の血清群のうち、血清群A、B、C、W、Yが、世界中の症例の大半の原因となっている主犯です。これらの血清群は、さまざまな年齢層や地域で予測不可能な循環をするため、各血清群を標的としたワクチンが必要です。
髄膜炎菌ワクチンの市場は、各国の国家予防接種プログラムでの採用の増加と世界的髄膜炎菌アウトブレイクの増加により、大幅な成長が見込まれています。これらのアウトブレイクにより、効果的なワクチンの需要が高まり、市場の成長が促進されています。ただし、新しいワクチンの承認に関する厳格な規制枠組みと汚染問題による製品リコールは、市場拡大の課題となっています。前向きな面では、髄膜炎菌ワクチンの継続的な研究開発と世界的な医療費の増加により、市場にとって有利な成長機会が生まれています。
2023年には北アメリカが市場をリードし、収益シェアは53％で、ヨーロッパがそれに続きました。北アメリカの優位性は、政府の好意的な推奨、多額の研究開発投資、堅牢な医療インフラ、広範な啓発キャンペーンに起因しています。対照的に、アジア太平洋地域は予測期間中に急速な成長が見込まれています。小児人口の増加や、病気の蔓延拡大に対抗するための積極的な政府の取り組みなどの要因が、この成長に貢献しています。この地域の非営利団体も、一般の人々や医療専門家の間で意識を広め、ワクチンの採用をさらに促進する上で重要な役割を果たしています。
目次
Table of Contents
Chapter 1. Global Meningococcal Vaccines Market Executive Summary
1.1. Global Meningococcal Vaccines Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Vaccine Serotype
1.3.2. By Vaccine Type
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Meningococcal Vaccines Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Meningococcal Vaccines Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Adoption in Immunization Programs
3.1.2. Surge in Meningococcal Outbreaks
3.2. Market Challenges
3.2.1. Stringent Government Regulations
3.2.2. Product Recalls Due to Contamination
3.3. Market Opportunities
3.3.1. Increase in R&D Activities
3.3.2. Rising Healthcare Expenditure
Chapter 4. Global Meningococcal Vaccines Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Meningococcal Vaccines Market Size & Forecasts by Vaccine Serotype 2022-2032
5.1. Segment Dashboard
5.2. Global Meningococcal Vaccines Market: Vaccine Serotype Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. MenACWY
5.2.2. MenB & Manic
5.2.3. MenC
5.2.4. MenA
5.2.5. MenAC
Chapter 6. Global Meningococcal Vaccines Market Size & Forecasts by Vaccine Type 2022-2032
6.1. Segment Dashboard
6.2. Global Meningococcal Vaccines Market: Vaccine Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Conjugate
6.2.2. Polysaccharide
6.2.3. Subcapsular
Chapter 7. Global Meningococcal Vaccines Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Meningococcal Vaccines Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Pediatric
7.2.2. Adult
7.2.3. Travelers
Chapter 8. Global Meningococcal Vaccines Market Size & Forecasts by Region 2022-2032
8.1. North America Meningococcal Vaccines Market
8.1.1. U.S. Meningococcal Vaccines Market
8.1.1.1. Vaccine Serotype breakdown size & forecasts, 2022-2032
8.1.1.2. Vaccine Type breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Meningococcal Vaccines Market
8.2. Europe Meningococcal Vaccines Market
8.2.1. U.K. Meningococcal Vaccines Market
8.2.2. Germany Meningococcal Vaccines Market
8.2.3. France Meningococcal Vaccines Market
8.2.4. Spain Meningococcal Vaccines Market
8.2.5. Italy Meningococcal Vaccines Market
8.2.6. Rest of Europe Meningococcal Vaccines Market
8.3. Asia-Pacific Meningococcal Vaccines Market
8.3.1. China Meningococcal Vaccines Market
8.3.2. India Meningococcal Vaccines Market
8.3.3. Japan Meningococcal Vaccines Market
8.3.4. Australia Meningococcal Vaccines Market
8.3.5. South Korea Meningococcal Vaccines Market
8.3.6. Rest of Asia Pacific Meningococcal Vaccines Market
8.4. Latin America Meningococcal Vaccines Market
8.4.1. Brazil Meningococcal Vaccines Market
8.4.2. Mexico Meningococcal Vaccines Market
8.4.3. Rest of Latin America Meningococcal Vaccines Market
8.5. Middle East & Africa Meningococcal Vaccines Market
8.5.1. Saudi Arabia Meningococcal Vaccines Market
8.5.2. South Africa Meningococcal Vaccines Market
8.5.3. Rest of Middle East & Africa Meningococcal Vaccines Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GlaxoSmithKline plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Pfizer Inc.
9.3.3. Sanofi Pasteur
9.3.4. Merck & Co., Inc.
9.3.5. Novartis AG
9.3.6. CSL Limited
9.3.7. Johnson & Johnson
9.3.8. Bharat Biotech International Limited
9.3.9. Serum Institute of India Pvt. Ltd.
9.3.10. Sinovac Biotech Ltd.
9.3.11. Biological E Limited
9.3.12. Chongqing Zhifei Biological Products Co., Ltd.
9.3.13. Beijing Tiantan Biological Products Co., Ltd.
9.3.14. Hualan Biological Engineering Inc.
9.3.15. Walvax Biotechnology Co., Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Meningococcal Vaccines market, report scope
TABLE 2. Global Meningococcal Vaccines market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Meningococcal Vaccines market estimates & forecasts by Vaccine Serotype 2022-2032 (USD Billion)
TABLE 4. Global Meningococcal Vaccines market estimates & forecasts by Vaccine Type 2022-2032 (USD Billion)
TABLE 5. Global Meningococcal Vaccines market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global Meningococcal Vaccines market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Meningococcal Vaccines market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Meningococcal Vaccines market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Meningococcal Vaccines market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Meningococcal Vaccines market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Meningococcal Vaccines market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Meningococcal Vaccines market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Meningococcal Vaccines market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Meningococcal Vaccines market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Meningococcal Vaccines market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Meningococcal Vaccines market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Meningococcal Vaccines market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Meningococcal Vaccines market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Meningococcal Vaccines market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Meningococcal Vaccines market estimates & forecasts by segment 2022-2032 (USD Billion)
…..
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Meningococcal Vaccines market, research methodology
FIG 2. Global Meningococcal Vaccines market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Meningococcal Vaccines market, key trends 2023
FIG 5. Global Meningococcal Vaccines market, growth prospects 2022-2032
FIG 6. Global Meningococcal Vaccines market, porters 5 force model
FIG 7. Global Meningococcal Vaccines market, PESTEL analysis
FIG 8. Global Meningococcal Vaccines market, value chain analysis
FIG 9. Global Meningococcal Vaccines market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Meningococcal Vaccines market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Meningococcal Vaccines market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Meningococcal Vaccines market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Meningococcal Vaccines market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Meningococcal Vaccines market, regional snapshot 2022 & 2032
FIG 15. North America Meningococcal Vaccines market 2022 & 2032 (USD Billion)
FIG 16. Europe Meningococcal Vaccines market 2022 & 2032 (USD Billion)
FIG 17. Asia pacific Meningococcal Vaccines market 2022 & 2032 (USD Billion)
FIG 18. Latin America Meningococcal Vaccines market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Meningococcal Vaccines market 2022 & 2032 (USD Billion)
FIG 20. Global Meningococcal Vaccines market, company market share analysis (2023)
…..
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.
